New Israeli drug cured 29 of 30 moderate to serious COVID-19 cases in days

Asia, Coronavirus, Health, Infection, Israel, Treatment

A new coronavirus treatment being developed at Tel Aviv’s Ichilov Medical Center has successfully completed phase 1 trials and appears to have helped numerous moderate-to-serious cases of COVID-19 quickly recover from the disease, the hospital said Friday.

Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days.

Times of Israel Report


Image by Michal Jarmoluk from Pixabay

** This post was originally published on February 5, 2021 **